Growth Metrics

Travere Therapeutics (TVTX) Cash from Investing Activities Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -114.28%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 826.39%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -674.01%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -166.24%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -122.45%
10 Travere Therapeutics 4.34 Bn 4.26 Bn 102.38 Mn -47.81%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -47.81%
Dec 31, 2025 -30.54%
Sep 30, 2025 87.73%
Jun 30, 2025 -83.05%
Mar 31, 2025 -60.64%
Dec 31, 2024 64.20%
Sep 30, 2024 -65.40%
Jun 30, 2024 221.47%
Mar 31, 2024 383.21%
Dec 31, 2023 -511.30%
Sep 30, 2023 1,222.73%
Jun 30, 2023 39.76%
Mar 31, 2023 -211.68%
Dec 31, 2022 -597.98%
Sep 30, 2022 -69.01%
Jun 30, 2022 45.55%
Mar 31, 2022 131.37%
Dec 31, 2021 105.87%
Sep 30, 2021 175.33%
Jun 30, 2021 -205.91%
Mar 31, 2021 -367.27%
Dec 31, 2020 -8,043.73%
Sep 30, 2020 -1,066.83%
Jun 30, 2020 168.74%
Mar 31, 2020 446.57%
Dec 31, 2019 103.24%
Sep 30, 2019 102.76%
Jun 30, 2019 -9.59%
Mar 31, 2019 45.27%
Dec 31, 2018 -47,280.58%
Sep 30, 2018 -7,283.23%
Jun 30, 2018 -36.24%
Mar 31, 2018 -605.48%
Dec 31, 2017 -100.34%
Sep 30, 2017 63.85%
Jun 30, 2017 1,119.76%
Mar 31, 2017 142.28%
Dec 31, 2016 130.33%
Sep 30, 2016 -111.59%
Jun 30, 2016 -176.37%
Mar 31, 2016 68.33%
Dec 31, 2015 -5,199.54%
Sep 30, 2015 2,631.36%
Jun 30, 2015 74.36%
Mar 31, 2015 0.97%
Dec 31, 2014 55.80%
Mar 31, 2014 -2,280.78%